NCT06778850View on ClinicalTrials.gov

A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight Participants

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

June 9, 2023

Primary Completion Date

July 15, 2025

Study Completion Date

December 30, 2025

Conditions
Overweight and Obese Volunteers
Interventions
DRUG

MDR-001

Oral administration of small molecule MDR-001 tablets

DRUG

palcebo

Administered orally placebo

Trial Locations (1)

Unknown

RECRUITING

The first hospital of Jilin University, Changchun

All Listed Sponsors
lead

MindRank AI Ltd

INDUSTRY